MedTrace Logo

Mass Balance Clinical Trial With TEV-56286

NCT06627231 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2025-01-29

No results posted yet for this study

Summary

Mass balance clinical trial with TEV-56286

Conditions

  • Healthy Participants

Interventions

DRUG

TEV-56286

Oral capsule

DRUG

[14C]-TEV-56286

Oral capsule

Sponsors & Collaborators

  • Teva Branded Pharmaceutical Products R&D, Inc.

    lead INDUSTRY

Principal Investigators

  • Teva Medical Expert, MD · Teva Branded Pharmaceutical Products R&D, Inc.

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-10-08
Primary Completion
2024-11-29
Completion
2024-11-29

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06627231 on ClinicalTrials.gov